Open Access
- 1 January 2024
- journal article
- research article
- Published by Medknow in Neural Regeneration Research
- Vol. 19 (1) , 156-157
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Saliva is a Good Candidate to be the New Gold-Standard Sample for Neurodegenerative DiseasesJournal of Alzheimer’s Disease, 2022
- B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patientsScientific Reports, 2022
- Salivary biomarkers of neurodegenerative and demyelinating diseases and biosensors for their detectionAgeing Research Reviews, 2022
- Oral-Gut-Brain Axis in Experimental Models of Periodontitis: Associating Gut Dysbiosis With Neurodegenerative DiseasesFrontiers in Aging, 2021
- Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosisJournal of Neuroimmunology, 2021
- Oral microbiota and Alzheimer’s disease: Do all roads lead to Rome?Pharmacological Research, 2020
- Salivary Biomarkers for Alzheimer’s Disease and Related DisordersNeurology and Therapy, 2019
- Salivary microR‐153 and microR‐223 Levels as Potential Diagnostic Biomarkers of Idiopathic Parkinson's DiseaseMovement Disorders, 2019
- Circulating miRNAs as Potential Biomarkers in Alzheimer's DiseaseJournal of Alzheimer’s Disease, 2014
- Decreased circulating miRNA levels in patients with primary progressive multiple sclerosisMultiple Sclerosis Journal, 2013